Nektar Therapeutics (NKTR)

Sector:Health Care
Super Investor Stats:
Ownership count:0
Ownership rank:--
% of all portfolios:0%
History Portfolio Manager Activity Share change % change to portfolio
Q3  2022
Lee Ainslie - Maverick Capital Sell 100.00% 3,218,382 0.31
Q2  2022
Lee Ainslie - Maverick Capital Reduce 32.85% 1,574,538 0.15
Q1  2022
Lee Ainslie - Maverick Capital Reduce 17.68% 1,029,684 0.10
Q4  2021
Lee Ainslie - Maverick Capital Reduce 0.27% 15,822 0.00
Q3  2021
Lee Ainslie - Maverick Capital Add 1.34% 77,353 0.02
Q2  2021
Lee Ainslie - Maverick Capital Reduce 1.66% 97,243 0.02
Q1  2021
Lee Ainslie - Maverick Capital Reduce 11.98% 797,309 0.15
Q4  2020
Lee Ainslie - Maverick Capital Add 17.21% 977,404 0.27
Q3  2020
Lee Ainslie - Maverick Capital Add 9.48% 491,584 0.15
Q2  2020
Lee Ainslie - Maverick Capital Add 5.88% 288,236 0.14
Q1  2020
Lee Ainslie - Maverick Capital Add 51.13% 1,657,167 0.62
Q4  2019
Lee Ainslie - Maverick Capital Buy 3,241,234 1.02
Q3  2019
Meridian Contrarian Fund Sell 100.00% 93,997 0.62
Q2  2019
Meridian Contrarian Fund Reduce 50.27% 95,000 0.63
Q1  2019
Meridian Contrarian Fund Reduce 23.48% 58,000 0.35
Q4  2018
Meridian Contrarian Fund Add 25.38% 50,000 0.33
Q1  2018
Meridian Contrarian Fund Reduce 54.19% 233,000 4.06
Q4  2017
Meridian Contrarian Fund Reduce 6.32% 29,000 0.28
Q2  2017
Meridian Contrarian Fund Add 15.04% 60,000 0.22
Q1  2017
Meridian Contrarian Fund Reduce 6.58% 28,101 0.13
Q3  2016
Meridian Contrarian Fund Reduce 9.63% 45,495 0.15
Q1  2016
Meridian Contrarian Fund Add 24.17% 91,988 0.25
Q3  2015
Meridian Contrarian Fund Add 9.49% 33,000 0.07
Q1  2015
Meridian Contrarian Fund Buy 347,605 0.59

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.